117 results on '"Stocchi, A."'
Search Results
2. Continuous subcutaneous levodopa/carbidopa infusion (ND0612) for patients with Parkinson’s disease and motor fluctuations: A Phase 3, active-controlled study (BouNDless)
3. Long-term safety of continuous levodopa/carbidopa infusion with ND0612: results from the ongoing BeyoND study
4. Comparison of pharmacokinetics of apomorphine (sublingual film or subcutaneous injection) between patients with Parkinson's disease in Europe and North America
5. Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease
6. Dose optimization of apomorphine sublingual film for treating “OFF” episodes in Parkinson's disease
7. Functional gait disorders: Demographic and clinical correlations
8. The spectrum of 'off' in Parkinson's disease: What have we learned over 40 years?
9. BouNDless: An active-controlled, randomised, double-blind, double-dummy trial of continuous subcutaneous infusion of levodopa/carbidopa with ND0612 in patients with Parkinson's disease
10. Effect of baseline dyskinesia on safety and efficacy of istradefylline, an A2A receptor antagonist, in Parkinson's disease: 8-study pooled analysis
11. Validity of the wall goniometer as a screening tool to detect postural abnormalities in Parkinson's disease
12. Effect of baseline dyskinesia on safety and efficacy of istradefylline, an A2A receptor antagonist, in Parkinson's disease: 8-study pooled analysis
13. BouNDless: An active-controlled, randomised, double-blind, double-dummy trial of continuous subcutaneous infusion of levodopa/carbidopa with ND0612 in patients with Parkinson's disease
14. The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system
15. The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?
16. The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease
17. The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease
18. The worse is the clinical status of the patient with Parkinson, the higher is the stride length percentage of improvement after Automated Mechanical Peripheral Stimulation
19. The worse is the clinical status of the patient with Parkinson, the higher is the stride length percentage of improvement after Automated Mechanical Peripheral Stimulation
20. Corrigendum to “Early detection of wearing off in Parkinson disease: The DEEP study” [Parkinsonism Relat Disorder 20 (2014) 204–211]
21. Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study
22. The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system
23. Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients
24. Corrigendum to 'Early detection of wearing off in Parkinson disease: The DEEP study' [Parkinsonism Relat Disorder 20 (2014) 204–211]
25. Characterizing motor and non-motor aspects of early-morning off periods in Parkinson's disease: An international multicenter study
26. Early DEtection of wEaring off in Parkinson disease: The DEEP study
27. 2.268 FIRST 2-YEAR, PLACEBO-CONTROLLED STUDY IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS INDICATES SAFINAMIDE MAY BENEFIT PATIENTS WITH MORE SEVERE DYSKINESIA
28. P2.165 Dose-related decrease in 'off' time with ropinirole prolonged release in patients with advanced Parkinson's disease
29. 2.268 FIRST 2-YEAR, PLACEBO-CONTROLLED STUDY IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS INDICATES SAFINAMIDE MAY BENEFIT PATIENTS WITH MORE SEVERE DYSKINESIA
30. 2.267 LONG-TERM EFFICACY OF SAFINAMIDE AS ADD-ON TO LEVODOPA IN PARKINSON'S DISEASE (PD) USING AN ‘ON’ AND ‘ON-OFF’ TREATMENT ANALYSIS
31. 1.108 DEEP STUDY: A LARGE EPIDEMIOLOGICAL SURVEY ABOUT WEARING OFF IN PARKINSON DISEASE
32. 2.8.2 HOW MUCH CAN WE INFLUENCE CLINICAL PROGRESSION OF PARKINSON'S DISEASE?
33. 2.267 LONG-TERM EFFICACY OF SAFINAMIDE AS ADD-ON TO LEVODOPA IN PARKINSON'S DISEASE (PD) USING AN ‘ON’ AND ‘ON-OFF’ TREATMENT ANALYSIS
34. 1.108 DEEP STUDY: A LARGE EPIDEMIOLOGICAL SURVEY ABOUT WEARING OFF IN PARKINSON DISEASE
35. 2.8.2 HOW MUCH CAN WE INFLUENCE CLINICAL PROGRESSION OF PARKINSON'S DISEASE?
36. The therapeutic concept of continuous dopaminergic stimulation (CDS) in the treatment of Parkinson's disease
37. Dopamine receptor agonists in the treatment of advanced Parkinson's disease
38. P2.164 Ropinirole prolonged release maintains an increase in daily awake time spent “on” in patients with advanced Parkinson's disease
39. O.057 Will continuous dopaminergic stimulation prevent motor complications?
40. P2.166 Once-daily ropinirole prolonged release improves activities of daily living and motor symptoms in patients with advanced Parkinson's disease
41. Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment
42. P2.171 Transdermal lisuride achieves stable plasma levels in Parkinson's disease (PD)
43. P2.165 Dose-related decrease in “off” time with ropinirole prolonged release in patients with advanced Parkinson's disease
44. The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease
45. P2.164 Ropinirole prolonged release maintains an increase in daily awake time spent 'on' in patients with advanced Parkinson's disease
46. O.057 Will continuous dopaminergic stimulation prevent motor complications?
47. P2.166 Once-daily ropinirole prolonged release improves activities of daily living and motor symptoms in patients with advanced Parkinson's disease
48. P2.171 Transdermal lisuride achieves stable plasma levels in Parkinson's disease (PD)
49. 3.IS.3.1 Patch technology as a novel option for continuous drug delivery
50. 2.252 Lisuride long term s.c. infusion in advanced Parkinson's disease patients unresponsive to oral treatments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.